J-Lex

Bonviva Tablets 100mg

Bonviva Tablets 100mg, manufactured by Taisho Pharmaceutical, contain Ibandronate sodium hydrate (YJ code: 3999040F1026, standard: 100mg 1 tablet). This bisphosphonate antiresorptive agent is approved for the treatment of osteoporosis, typically taken once a month.

← Back to search

Need more detailed information?

Contact TASAKI PHARMA for inquiries about this medicine (English support available).

Contact us about this drug →

More with the same ingredient

More from this manufacturer